top of page

Advancing High-Potency and OSD Manufacturing for Global Markets

EU GMP-approved development and manufacturing for tablets, capsules, softgels, and high-potency oral solid dose products- supporting programmes intended for EU (EMA), US (FDA), and global (PMDA) regulatory pathways.

Achieve Excellence Together 

Eirgen Pharma is a Contract Development and Manufacturing Organization based in Waterford, Ireland. We specialize in high-potency and oral solid dose (OSD) medicines for human and animal health, with established expertise across oncology and other complex therapeutic areas.

​

We support partners from early formulation and IMP supply through to commercial OSD manufacturing and packaging. Our facilities operate under EU GMP (HPRA) oversight and are designed to meet the expectations of global regulators including the FDA and EMA. 

Our Core Capabilities

ORAL SOLID DOSE &  MANUFACTURING

Advance your high‑potency and OSD tablets and capsules with a partner that reduces risk and improves speed to market.

SOFTGEL DEVELOPMENT & MANUFACTURING

Develop capsules that maximise bioavailability, improve stability, and deliver a more convenient patient experience.

HIGH POTENCY & CYTOTOXIC CAPACITY

Our purpose‑built containment facilities safely manufacture oncology and other high‑potency OSD products.

COMPANION ANIMAL HEALTH

We help companies develop and manufacture reliable veterinary medicines tailored to their specific needs.

Learn More About Us

Knowledge Hub

Information and resources, including news, whitepapers, and events 

Facilities

Purpose-built to support the development, manufacturing, and packaging of highly-potent and non potent OSD. 

Quality

Highest quality standards maintained, with a proven track record of zero FDA 483 observations.

Careers

Explore our open positions across a range of disciplines, such as engineering, R&D, and chemistry. 

bottom of page